Integrin β4 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses

Weiguo Chen, Joe GN Garcia, Jeffrey R. Jacobson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We previously identified the marked upregulation of integrin β4 in human lung endothelial cells (EC) treated with simvastatin, an HMG coA-reductase inhibitor with vascular-protective and anti-inflammatory properties in murine models of acute lung injury (ALI). We now investigate the role of integrin β4 as a novel mediator of vascular inflammatory responses with a focus on mitogen-activated protein kinases (MAPK) signaling and the downstream expression of the inflammatory cytokines (IL-6 and IL-8) essential for the full elaboration of inflammatory lung injury. Silencing of integrin β4 (siITGB4) in human lung EC resulted in significant increases in both basal and LPS-induced phosphorylation of ERK 1/2, JNK, and p38 MAPK, consistent with robust integrin β4 regulation of MAPK activation. In addition, siITB4 increased both basal and LPS-induced expression of IL-6 and IL-8 mRNA and protein secretion into the media. We next observed that integrin β4 silencing increased basal and LPS-induced phosphorylation of SHP-2, a protein tyrosine phosphatase known to modulate MAPK signaling. In contrast, inhibition of SHP-2 enzymatic activity (sodium stibogluconate) abrogated the increased ERK phosphorylation associated with integrin β4 silencing in LPS-treated EC and attenuated the increases in levels of IL-6 and IL-8 in integrin-β4- silenced EC. These findings highlight a novel negative regulatory role for integrin β4 in EC inflammatory responses involving SHP-2-mediated MAPK signaling. Upregulation of integrin β4 may represent an important element of the anti-inflammatory and vascular-protective properties of statins and provides a novel strategy to limit inflammatory vascular syndromes.

Original languageEnglish (US)
Pages (from-to)718-724
Number of pages7
JournalJournal of Cellular Biochemistry
Volume110
Issue number3
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Mitogen-Activated Protein Kinase 1
Integrins
Lung
Endothelial cells
Mitogen-Activated Protein Kinases
Endothelial Cells
Phosphorylation
Blood Vessels
Interleukin-8
Interleukin-6
Non-Receptor Type 11 Protein Tyrosine Phosphatase
Anti-Inflammatory Agents
Up-Regulation
Antimony Sodium Gluconate
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Protein Tyrosine Phosphatases
Simvastatin
JNK Mitogen-Activated Protein Kinases
Acute Lung Injury
Lung Injury

Keywords

  • Endothelial cells
  • Inflammation
  • Integrins

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Integrin β4 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses. / Chen, Weiguo; Garcia, Joe GN; Jacobson, Jeffrey R.

In: Journal of Cellular Biochemistry, Vol. 110, No. 3, 01.06.2010, p. 718-724.

Research output: Contribution to journalArticle

@article{88fb99cd817a4686985e46434c4ff655,
title = "Integrin β4 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses",
abstract = "We previously identified the marked upregulation of integrin β4 in human lung endothelial cells (EC) treated with simvastatin, an HMG coA-reductase inhibitor with vascular-protective and anti-inflammatory properties in murine models of acute lung injury (ALI). We now investigate the role of integrin β4 as a novel mediator of vascular inflammatory responses with a focus on mitogen-activated protein kinases (MAPK) signaling and the downstream expression of the inflammatory cytokines (IL-6 and IL-8) essential for the full elaboration of inflammatory lung injury. Silencing of integrin β4 (siITGB4) in human lung EC resulted in significant increases in both basal and LPS-induced phosphorylation of ERK 1/2, JNK, and p38 MAPK, consistent with robust integrin β4 regulation of MAPK activation. In addition, siITB4 increased both basal and LPS-induced expression of IL-6 and IL-8 mRNA and protein secretion into the media. We next observed that integrin β4 silencing increased basal and LPS-induced phosphorylation of SHP-2, a protein tyrosine phosphatase known to modulate MAPK signaling. In contrast, inhibition of SHP-2 enzymatic activity (sodium stibogluconate) abrogated the increased ERK phosphorylation associated with integrin β4 silencing in LPS-treated EC and attenuated the increases in levels of IL-6 and IL-8 in integrin-β4- silenced EC. These findings highlight a novel negative regulatory role for integrin β4 in EC inflammatory responses involving SHP-2-mediated MAPK signaling. Upregulation of integrin β4 may represent an important element of the anti-inflammatory and vascular-protective properties of statins and provides a novel strategy to limit inflammatory vascular syndromes.",
keywords = "Endothelial cells, Inflammation, Integrins",
author = "Weiguo Chen and Garcia, {Joe GN} and Jacobson, {Jeffrey R.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1002/jcb.22582",
language = "English (US)",
volume = "110",
pages = "718--724",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Integrin β4 attenuates SHP-2 and MAPK signaling and reduces human lung endothelial inflammatory responses

AU - Chen, Weiguo

AU - Garcia, Joe GN

AU - Jacobson, Jeffrey R.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - We previously identified the marked upregulation of integrin β4 in human lung endothelial cells (EC) treated with simvastatin, an HMG coA-reductase inhibitor with vascular-protective and anti-inflammatory properties in murine models of acute lung injury (ALI). We now investigate the role of integrin β4 as a novel mediator of vascular inflammatory responses with a focus on mitogen-activated protein kinases (MAPK) signaling and the downstream expression of the inflammatory cytokines (IL-6 and IL-8) essential for the full elaboration of inflammatory lung injury. Silencing of integrin β4 (siITGB4) in human lung EC resulted in significant increases in both basal and LPS-induced phosphorylation of ERK 1/2, JNK, and p38 MAPK, consistent with robust integrin β4 regulation of MAPK activation. In addition, siITB4 increased both basal and LPS-induced expression of IL-6 and IL-8 mRNA and protein secretion into the media. We next observed that integrin β4 silencing increased basal and LPS-induced phosphorylation of SHP-2, a protein tyrosine phosphatase known to modulate MAPK signaling. In contrast, inhibition of SHP-2 enzymatic activity (sodium stibogluconate) abrogated the increased ERK phosphorylation associated with integrin β4 silencing in LPS-treated EC and attenuated the increases in levels of IL-6 and IL-8 in integrin-β4- silenced EC. These findings highlight a novel negative regulatory role for integrin β4 in EC inflammatory responses involving SHP-2-mediated MAPK signaling. Upregulation of integrin β4 may represent an important element of the anti-inflammatory and vascular-protective properties of statins and provides a novel strategy to limit inflammatory vascular syndromes.

AB - We previously identified the marked upregulation of integrin β4 in human lung endothelial cells (EC) treated with simvastatin, an HMG coA-reductase inhibitor with vascular-protective and anti-inflammatory properties in murine models of acute lung injury (ALI). We now investigate the role of integrin β4 as a novel mediator of vascular inflammatory responses with a focus on mitogen-activated protein kinases (MAPK) signaling and the downstream expression of the inflammatory cytokines (IL-6 and IL-8) essential for the full elaboration of inflammatory lung injury. Silencing of integrin β4 (siITGB4) in human lung EC resulted in significant increases in both basal and LPS-induced phosphorylation of ERK 1/2, JNK, and p38 MAPK, consistent with robust integrin β4 regulation of MAPK activation. In addition, siITB4 increased both basal and LPS-induced expression of IL-6 and IL-8 mRNA and protein secretion into the media. We next observed that integrin β4 silencing increased basal and LPS-induced phosphorylation of SHP-2, a protein tyrosine phosphatase known to modulate MAPK signaling. In contrast, inhibition of SHP-2 enzymatic activity (sodium stibogluconate) abrogated the increased ERK phosphorylation associated with integrin β4 silencing in LPS-treated EC and attenuated the increases in levels of IL-6 and IL-8 in integrin-β4- silenced EC. These findings highlight a novel negative regulatory role for integrin β4 in EC inflammatory responses involving SHP-2-mediated MAPK signaling. Upregulation of integrin β4 may represent an important element of the anti-inflammatory and vascular-protective properties of statins and provides a novel strategy to limit inflammatory vascular syndromes.

KW - Endothelial cells

KW - Inflammation

KW - Integrins

UR - http://www.scopus.com/inward/record.url?scp=77952676205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952676205&partnerID=8YFLogxK

U2 - 10.1002/jcb.22582

DO - 10.1002/jcb.22582

M3 - Article

VL - 110

SP - 718

EP - 724

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 3

ER -